Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate
Topical corticosteroids are effective in reducing anterior segment inflammation but are associated with adverse drug reactions (ADRs) including elevation of intraocular pressure (IOP) and cataract formation. Retrometabolic drug design has advanced the development of new corticosteroids with improved...
Saved in:
Main Authors: | Timothy L. Comstock, Heleen H. DeCory |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | International Journal of Inflammation |
Online Access: | http://dx.doi.org/10.1155/2012/789623 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current Approach of Corticosteroids Use in Ocular Therapy.
by: Dayamí Pérez Gómez, et al.
Published: (2011-08-01) -
Ocular Inflammation
by: Valentín Huerva, et al.
Published: (2015-01-01) -
Ocular Inflammation and Infection
by: Michelle Callegan, et al.
Published: (2012-01-01) -
Inhaled Corticosteroid Therapy Does Not Control Asthma
by: Robert L Cowie, et al.
Published: (2004-01-01) -
Optimizing corticosteroid therapy in takayasu arteritis
by: Pallavi Patro
Published: (2022-01-01)